ES EN
Menu Menú

Publications

Publicaciones

Search Publications

Buscar publicaciones

Filters Filtro de búsqueda

to a

clear selection Quitar los filtros

none

Article Artículo

تحریم های آمریکا برای مرگ طراحی شده اند
در حال حاضر تحریم های آمریکا هزاران ایرانی را می ‌‌کشند. با کنترل سیستم بانکی دنیا، قدرت تحریم گذاری آمریکا حقوق بشر را پایمال میکند و دنیا را تهدید می‌کند

Kevin Cashman and Cavan Kharrazian / September 18, 2019

Article Artículo

Government

United States

Workers

The Crazy in Economic Data
Just as we saw President Trump looking like a fool with his Sharpie-altered hurricane map, perhaps we will see him holding up a chart showing a half percentage point drop in the unemployment rate on the last Friday before next year’s election.

Dean Baker / September 16, 2019

Article Artículo

Healthcare

Health Care Premiums and Taxes

There's an old joke about a lawyer who is questioning a doctor on an autopsy they had done on someone who was allegedly a murder victim.

The lawyer asked the doctor, "did you check whether the patient was breathing?"

The doctor answers "no."

The lawyer then asks "did you check whether the patient had a pulse?"

The doctor again answers "no."

The lawyer then asks, "so how did you know that the patient was dead," to which the doctor responds, "because his brains were sitting in a jar on my desk."

The lawyer then triumphantly asks, "so he could have still been alive?" To which the doctor responds, "I suppose he could have been practicing law somewhere."

Our doctor may want to amend their answer to allow for the possibility that the patient could be a political pundit for a leading news outlet.

Our pundit class have to decided to make a crusade out of forcing Senators Warren and Sanders into saying that their proposals for universal Medicare will require a tax increase. Both have repeatedly responded by saying that total costs for the vast majority of people will fall, since Medicare for All will lead to a large reduction in costs by all accounts, because it reduces waste in the health care system.

Our pundit class have insisted that this is some sort of dodge. While there may be no hope in addressing arguments to people who have their brains in a jar on a doctor's desk, there is a simple point that everyone else should understand.

CEPR / September 14, 2019

Article Artículo

Patents and Copyright: Protection Racket for Intellectuals

Last week I was asked on Twitter why proposals for replacing patent monopoly financing of prescription drugs with direct public financing have gained so little traction. After all, this would mean that drugs would be cheap; no one would have to struggle with paying tens or hundreds of thousands of dollars for drugs that are needed for their health or to save their life. (This is discussed in chapter 5 of Rigged [it’s free].)

Public funding would also eliminate the incentive to misrepresent the safety and effectiveness of drugs in order to maximize sales at the patent monopoly price. Without patent monopolies, the drug companies would not have had the same incentive to push opioids, as well as many other drugs of questionable safety and effectiveness.

The idea of direct funding of biomedical research also should not seem strange to people. We currently spend close to $45 billion a year on research through the National Institutes of Health and other government agencies. The idea of doubling or tripling this funding to replace the roughly $70 billion of patent supported research now done by the pharmaceutical industry, should not appear outlandish, especially since the potential savings from free-market drugs would be close to $400 billion annually (1.9 percent of GDP).

So why is there so little interest in reforming the prescription drug industry along these lines? I can think of two plausible answers. The first is a self-serving one for the elites who dominate policy debates. They don’t like to have questions raised about the basic underpinnings of the distribution of income.

The second is perhaps a more simple proposition. Intellectuals have a hard time dealing with new ideas and paying for innovation outside of the patent system or creative work outside of the copyright system is a new idea that most intellectual types would rather not wrestle with.

CEPR / September 13, 2019